3-Methyl-2-nitrobenzoic acid

CAS No. 5437-38-7

3-Methyl-2-nitrobenzoic acid( —— )

Catalog No. M28632 CAS No. 5437-38-7

3-Methyl-2-nitrobenzoic acid is in agricultural chemicals such as With Preparation in be used as intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 29 In Stock
25MG 51 In Stock
50MG 75 In Stock
100MG 112 In Stock
200MG Get Quote In Stock
500MG 276 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Methyl-2-nitrobenzoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Methyl-2-nitrobenzoic acid is in agricultural chemicals such as With Preparation in be used as intermediate.
  • Description
    3-Methyl-2-nitrobenzoic acid is in agricultural chemicals such as With Preparation in be used as intermediate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5437-38-7
  • Formula Weight
    181.15
  • Molecular Formula
    C8H7NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cccc(C(O)=O)c1[N+]([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Capolupo A, et al. Determination of Gymnemic Acid I as a Protein Biosynthesis Inhibitor Using Chemical Proteomics. J Nat Prod. 2017 Apr 28;80(4):909-915.
molnova catalog
related products
  • Albizziin

    Albizziin is a glutamase inhibitor and is a glutaminyl-tRNA synthetase inhibitor.

  • Cucurbitacin C

    Cucurbitacin C is a triterpenoid calabinoid that can be isolated from Cucurbitaceae plants. Cucurbitacin C has anti-cancer activity in vivo and in vitro. Cucurbitacin C can induce cell cycle arrest in G1 or G2/M phase and apoptosis by inhibiting Akt signaling.

  • UCL 2077

    UCL 2077 is a subtype-selective blocker of the epilepsy-associated KCNQ channels and it also is a selective slow-afterhyperpolarization channel blocker.